Berkeley Lights Sets IPO For Its Single Cell Manipulation Platform

The Emeryville, CA-based company will offer 7.4 million shares to raise $126 million at $16 to $18 per share, which translates into a fully diluted market value of $1.2 billion. Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. … Read more

Categories IPO

IPO: Yield10 Bioscience, Inc

IPO: Yield10 Bioscience, Inc

Global food security is a big concept for a small company. To achieve its lofty goals, Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yields. The company has an extensive track record of innovation based around optimizing the flow of carbon in living systems, and it is leveraging … Read more

IPO: Amyris, Inc

IPO: Amyris, Inc

Amyris, Inc is unique in many ways, but a synthetic biology company with a fifteen year history makes it a rare entity in a new, formative-stage industry. In 2005, Amyris partnered with the Bill & Melinda Gates Foundation to engineer yeast to make artemisinic acid, a precursor of artemisinin, an effective anti-malarial drug. In 2008, … Read more

Categories IPO

Twist Bioscience Corporation IPO

Twist Bioscience Corporation IPO

TWIST Bioscience Corp (symbol: TWST) is a leading and rapidly growing synthetic biology company that has developed a DNA synthesis platform to industrialize the engineering of biology. Twist is an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Startups Act … Read more

Categories IPO